HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 26, Nos. 11 & 12, November & December 2022 – Worlds Within Worlds – Viruses, Humanity, and the Environment       » Pinpointing How This Key Protein Facilitates Viral Transmission From Insects to Plants       » A New Approach to Treating Organic Wastewater       » Using Old Plants for New Tricks?       » Using Gas Bubbles as Lenses to View Tissues More Deeply       » Seawater as a Renewable Energy Source       » Generating Oxygen Within Cells
Vol 26, No. 01, January 2022   |   Issue PDF view/purchase
EDITOR'S LETTER
New Year, New Drugs

The field of pharmacology has been around for a long time with the first recorded prescriptions finding roots in Ancient Mesopotamia. Since then, drug development and manufacturing has made tremendous advancements. From growing and collecting herbs, we have progressed to utilising new tools and modern equipment to manufacture synthetic drugs. What began as a couple of hundred herbs our ancestors had at their disposal, we now have over 20,000 drugs approved by the Federal Drug Administration in the market with many more in the pipeline.

As we usher in the new year, what are some discoveries and innovations we can look forward to within the field of pharmacology?

In this issue, we have Dr Harish Dave, Co-Founder and Chief Medical Officer of AUM Biosciences, to discuss today’s shifting paradigm in oncology drug development towards highly selective, minimally toxic, and patient-centric treatments (p.18) and an interview with Liu Qun, Head of IQVIA, China, to share with us more about the Chinese biopharmaceutical market (p.34). We also learn of a novel peptide that can facilitate the delivery of biomacromolecules to cells without killing them (p.6), how we may repurpose antihypertensive drugs for cerebral small vessel disease (p.55), and a potential new drug to better manage obesity (p.56).

Moving away from biopharmaceuticals, antimicrobial resistance has been a cause of concern in recent years and this month, we have a contribution from Jade Pallett, Chief Technology Officer for Zoono UK & Europe, to shed light on how antimicrobial coatings outdo traditional methods of disinfection (p.22). Then, in light of the fourth medical revolution, we speak to Mr Willson Deng, CEO of Arcstone, on the role of digital technology in supporting MedTech manufacturing (p.28).

Finally, in Columns, we have an article contribution from A/Prof Alexandra Sharland, Dr Nicole Mifsud, and Eric Son to elucidate how understanding antigen-specificity of host T cells can reduce organ transplantation rejection (p.14).

As we embark on a new year, the APBN team have lined up some exciting content we can’t wait to share with you. Thank you all for your support and have a happy new year!


Carmen Chan
Editor
You can reach me at [email protected]

 

You can always access all APBN's issues on our website: www.asiabiotech.com.
Check us out at Facebook @Asia Pacific Biotech News, Instagram @asiabiotech, or follow us on Twitter @asia_biotech.

 

NEWS CRUNCH  
news analytica Vietnam Exhibition Returns to Reunite the Industry After Its 4-Year Hiatus
news 2022 PDA Aseptic Processing of Biopharmaceuticals Conference
news Thailand LAB INTERNATIONAL, Bio Asia Pacific, and FutureCHEM INTERNATIONAL are ready to offer the Science and Technology Industry complete solutions this September!
news Better together: registration opens for Vitafoods Asia 2022 co-located with Fi Asia in October
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   [email protected] or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   [email protected]
Copyright© 2022 World Scientific Publishing Co Pte Ltd  •  Privacy Policy